Interferon-γ decreases ATP-binding cassette subfamily G member 1-mediated cholesterol efflux through small ubiquitin-like modifier/ubiquitin-dependent liver X receptor-α degradation in macrophages
Interferon-γ decreases ATP-binding cassette subfamily G member 1-mediated cholesterol efflux through small ubiquitin-like modifier/ubiquitin-dependent liver X receptor-α degradation in macrophages
复制标题
干扰素-γ 通过巨噬细胞中的小型泛素样修饰剂/泛素依赖性肝脏 X 受体-α 降解,减少 ATP 结合盒亚家族 G 成员 1 介导的胆固醇流出
DOI:
10.1002/bab.2063
复制
发表时间:
2020-12-18
影响因子:
2.8
通讯作者:
Zhou, Juan
中科院分区:
文献类型:
--
作者:
Dong, Mengya;Zhang, Yan;Zhou, Juan
The effects of interferon-gamma (IFN-gamma) on cholesterol accumulation and the development of foam cells are still unclear. In the present study, we found that IFN-gamma promoted liver X receptor (LXR)-alpha degradation through the ubiquitin-proteasome system in macrophages. The process was dependent on its interactions with phosphorylated signal transducer and activator of transcription 1 (p-STAT1) and protein inhibitor of activated STAT 1 (PIAS1) because both fludarabine and PIAS1 shRNA reversed the decrease in LXR-alpha protein expression induced by IFN-gamma. Additionally, IFN-gamma enhanced the interactions of ubiquitin-conjugating enzyme 9 (UBC9), small ubiquitin-like modifier (SUMO)-1 and SUMO-2/3 with LXR-alpha. Moreover, treatment with shRNA specific for them not only reduced LXR-alpha polyubiquitination but also reversed the IFN-gamma-induced decrease in its expression. Two specific sumoylation sites in LXR-alpha, K22 and K326, were indispensable for its IFN-gamma-induced polyubiquitination because the K22R and K326R mutations inhibited the polyubiquitination and degradation of LXR-alpha in IFN-gamma-treated macrophages. In addition, K22R or K326R mutation almost completely restored ATP-binding cassette subfamily G member 1 (ABCG1)-mediated cholesterol efflux in IFN-gamma-treated macrophages. Taken together, these findings indicate that IFN-gamma promotes LXR-alpha degradation through a SUMO-ubiquitin-dependent pathway, which may inhibit cholesterol efflux mediated by ABCG1 from macrophages and promote the development of atherosclerosis.